Scholarly Works

In severe chronic rhinosinusitis with polyps and...

Journal article

In severe chronic rhinosinusitis with polyps and asthma, dupilumab improved nasal polyp score and sense of smell vs. omalizumab at 24 wk.

Abstract

CLINICAL IMPACT RATINGS: GIM/FP/GP: [Formula: see text] Allerg & Immunol: [Formula: see text] Pulmonology: [Formula: see text].

Authors

Chu DK; Rank MA

Journal

Annals of Internal Medicine, Vol. 179, No. 2,

Publisher

American College of Physicians

Publication Date

February 1, 2026

DOI

10.7326/annals-25-05457-jc

ISSN

1056-8751

Associated Experts

Derek Chu

Assistant Professor, Faculty of Health Sciences

Labels

Fields of Research (FoR)

32 Biomedical and Clinical Sciences 3202 Clinical Sciences

Sustainable Development Goals (SDG)

3 Good Health and Well Being

Medical Subject Headings (MeSH)

Humans Omalizumab Nasal Polyps Antibodies, Monoclonal, Humanized Sinusitis Asthma Chronic Disease Rhinitis Female Male Middle Aged Smell Adult Severity of Illness Index Aged Anti-Asthmatic Agents Rhinosinusitis

View published work (Non-McMaster Users)

View published work (McMaster Users)

Contact the Experts team

Get technical help

or

Provide website feedback